Marksans Pharma consolidated net profit declines 4.44% in the March 2024 quarter

Sales rise 15.23% to Rs 560.01 crore

Net profit of Marksans Pharma declined 4.44% to Rs 78.29 crore in the quarter ended March 2024 as against Rs 81.93 crore during the previous quarter ended March 2023. Sales rose 15.23% to Rs 560.01 crore in the quarter ended March 2024 as against Rs 485.98 crore during the previous quarter ended March 2023.

For the full year,net profit rose 17.80% to Rs 313.70 crore in the year ended March 2024 as against Rs 266.31 crore during the previous year ended March 2023. Sales rose 17.56% to Rs 2177.41 crore in the year ended March 2024 as against Rs 1852.14 crore during the previous year ended March 2023.

ParticularsQuarter EndedYear EndedMar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var.Sales560.01485.98 15 2177.411852.14 18 OPM %19.5822.54 -21.0618.32 - PBDT121.33118.12 3 497.80389.51 28 PBT100.28104.17 -4 423.53337.65 25 NP78.2981.93 -4 313.70266.31 18

Powered by Capital Market - Live News